Dongkoo Bio&Pharma Co's quarterly market cap
declined
from Jun. 2024 (₩188,384 Mil) to Sep. 2024 (₩155,109 Mil) and
declined
from Sep. 2024 (₩155,109 Mil) to Dec. 2024 (₩129,926 Mil).
Dongkoo Bio&Pharma Co's annual market cap
declined
from Dec. 2022 (₩169,611 Mil) to Dec. 2023 (₩156,261 Mil) and
declined
from Dec. 2023 (₩156,261 Mil) to Dec. 2024 (₩129,926 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dongkoo Bio&Pharma Co's Enterprise Value for Today is ₩196,404 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dongkoo Bio&Pharma Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Dongkoo Bio&Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dongkoo Bio&Pharma Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dongkoo Bio&Pharma Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Dongkoo Bio&Pharma Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Dongkoo Bio&Pharma Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dongkoo Bio&Pharma Co (XKRX:006620) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Dongkoo Bio&Pharma Co Market Cap Related Terms
Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:006620 has been successfully added to your 